)
)
Exelixis Investor Relations Material
Latest events
Q3 2024
Exelixis
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Exelixis Inc
Access all reports
Exelixis, Inc., is a US-based biotechnology company within oncology. The company focuses on the discovery, development, and commercialization of new medicines to treat cancers in the U.S. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its products also comprise MINNEBRO tablets for the treatment of genetic conditions.
Key slides for Exelixis Inc
Q1 2024
Exelixis Inc
Q2 2024
Exelixis Inc
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
EXEL
Country
🇺🇸 United States